tirzepatide rheumatoid arthritis GLP-1 Drugs Reduce Symptoms, Study Suggests Tirzepatide and autoimmune disease: what

It is also worth holding in mind the general clinical principle I raised earlier: if the musculoskeletal presentation of a patient with a known or suspected endocrine disorder does not fully match the history or mechanism, consider whether the endocrine condition may be contributing to the symptom picture

GIP receptor agonism affects gastric emptying differently than GLP-1 agonism alone

This may show anti-inflammatory and anti-fibrotic action

One tablespoon of healthy fat ties it together

Were no longer limited to restrictive diets that leave you hungry and exhausted, or extreme measures that feel unsustainable

Prevents fat accumulation by inhibiting lipogenesis, making it harder for the body to store excess fat